Patents - stay tuned to the technology

Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Elemental iodine or iodine compound

Subclass of:

424 - Drug, bio-affecting and body treating compositions

424600000 - INORGANIC ACTIVE INGREDIENT CONTAINING

Patent class list (only not empty are listed)

Deeper subclasses:

Class / Patent application numberDescriptionNumber of patent applications / Date published
424667000 Elemental iodine or iodine compound 38
20080248135Combination Therapy for Otitis with Antiseptic and pH Adjustment - Otitis is treated with a combination of a controlled-release iodine preparation and a pH-lowering preparation. This prevents or delays the onset of antibiotic resistance among causative bacteria and fungi, and, by inhibiting protease activity, improves the rate of healing, and prevents 10-09-2008
20090004296Antiseptic Compositions and Methods of Using Same - A novel antiseptic composition comprising an antiseptic in a carrier composition comprising nanostructures and a liquid and methods of use thereof are provided.01-01-2009
20090017139Iodine therapy dosing for treating medical conditions - A method for therapeutically treating medical conditions requiring chronic therapy such as fibrocystic breast disease, endometriosis, ovarian cysts, uterine fibroids and including the treatment of women considered to be at risk to breast and/or ovarian cancer without causing an overt thyroid disease by first administering to a patient a daily loading dose of molecular iodine (I01-15-2009
20090022816Storable, consumable pre-nascent iodine - This discovery is storable, pre-nascent iodine that activates and: produces nascent iodine over a two-to-three-hour period within the body when diluted in water and consumed. The iodine is in a low concentration in a tincture of grain alcohol. A quantity of tincture is submerged in a glass container in an electrolytic bath between two electrodes and subjected to a specific amperage for a period of time. This action causes the diatomic bond of the iodine molecule to be broken with the iodine atom receiving excitation energy from the magnetic field. When diluted and consumed into the body, the nascent iodine is able to produce significant beneficial effects in the body.01-22-2009
20090041859Wound Treatment Drugs for External Use - [Problems] The objective is to provide a new low-toxic drug for external use for intractable diseases, such as erosion, decubitus, and skin ulcer, that prevents cicatrization and reduces iodine accumulation on wound surfaces with sufficiently promoting healing.02-12-2009
20090123569Coverage indicating technology for skin sealants using tannates - A composition having various color changing tannates may be used to indicate that the composition has dried. The tannates change color in contact with an acid. The composition may be, for example, a skin prep, skin sealant, food product, paint or other building material or other product that undergoes a phase change. The tannate may be added either directly to the composition, incorporated into a sponge on an applicator through which the composition is dispensed and applied, applied separately or applied simultaneously from a separate reservoir. The amount of tannate in the composition can be adjusted to provide a visual cue to the user of the application area and the extent of cure.05-14-2009
20090142415Selective resonance of chemical structures - Chemical compositions may be selectively or preferentially excited by the application of scores comprising a series of energy inputs.06-04-2009
20100021566REVERSE VITAMIN K EFFECT VIA PHOTODYNAMIC OXIDATION TARGETED AT VASCULAR ENDOTHELIUM, FIBRIN AND BLOOD PLATELETS - A formulation or preparation for treating and preventing arterial and venous thrombi is provided. This preparation includes a non-metal containing photodynamic dye and a fat soluble vitamin. A method of administration for treatment and prophylaxis of arterial and venous thrombi is also provided. This method includes steps of: combining a non-metal containing photodynamic dye and a fat soluble vitamin; combining the non-metal containing photodynamic dye and fat soluble vitamin with a sodium solution; and administering the combination of non-metal containing photodynamic dye, fat soluble vitamin, and sodium solution as an intravenous drip.01-28-2010
20100068304COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING CARDIOVASCULAR DISEASES IN FELINES WITH HYPERTHYROIDISM - The invention relates to compositions for preventing and/or treating cardiovascular diseases in felines with hyperthyroidism wherein the compositions comprise from about 0.07 to less than about 1 mg/kg iodine and/or from about 0.1 to about 1.3 mg/kg selenium. The invention also relates to methods for preparing and using such compositions. articles of manufacture comprising such compositions, and means for communicating information about such compositions. methods, and articles of manufacture.03-18-2010
20100151053SYSTEM AND METHOD FOR THE DELIVERY OF A SANITIZING FOAM - A spray solution generates a foam to sanitize surfaces. The spray dip solution is a mixture of the solution with carbon dioxide and nitrous oxide in a closed vessel. After ejecting the liquid dip solution mixture from a nozzle a foam is generated from the solution as the solution hits a surface. The spray can be applied to a number of different surfaces. In an embodiment of the invention, the spray can be applied to cow teats without risk of cross-contamination of the nozzle or other equipment. The generated foam remains intact on the teat for a prolonged period of time, increases the area of the teat in contact with the foam during the treatment period and disperses skin-conditioning fats present in the dip treatment, thereby increasing the coverage of the skin conditioner on and within the epidermis of the teat and surrounding areas.06-17-2010
20100203166METHODS OF PREVENTING RESPIRATORY INFECTIONS - Methods for inhibiting the development of respiratory infections in humans are disclosed. One embodiment of the methods comprises pouring a predetermined amount of an oral rinse, capable of rendering ineffective a pathogen which has recently infected the respiratory tract, into the mouth of the human, agitating the oral rinse with air for a predetermined period in order to generate concentrated vapor of the oral rinse, stopping the agitating a plurality of times during which the head is tilted forward to allow the predetermined amount of an oral rinse to move away from the back of the mouth and throat, then exhaling before inhaling such that the concentrated vapor of the oral rinse is gently forced along with exhaled air from the throat thorough the nasopharynx and the nasal passages of the human, and then inhaling slowly to pass air over the oral rinse in the mouth such that concentrated vapor of the oral rinse is gently forced along with inhaled air through the larynx, over the vocal cords, and through the trachea to the lungs. The method is performed within about one hour after the human experiences the first minor symptom and before the onset of the first major symptom of infection of the respiratory tract.08-12-2010
20100260870METHOD AND PREPARATIONS FOR TREATING INFECTION-ALLERGIC DISEASES - The invention relates to medicine. The inventive method for treating infection-allergic diseases and viral infections involves the administering to a patient a preparation which is used in the form of a chemotherapeutic agent and contains the following components: 9 drops of 5% alcoholic iodine solution, 3.3 g of table salt and 0.5 1 of water. Physiotherapeutic procedures are carried out in the form of baths of an agent which contains the following components: cinnamon—3 g, the 5% alcoholic iodine solution—20 ml, table salt—250 g, water 140 1 and potato starch—25 g. In addition the patient receives as a chemotherapeutic agent for the liver probing, a preparation containing the following components: table salt 0.5 teaspoon, 9% table alcohol vinegar—1 teaspoon and boiled water 200-250 ml.10-14-2010
20120021071USE OF A SYNERGISTIC COMBINATION OF HYPOTHIOCYANITE AND/OR HYPOHALITE IONS AND LACTOFERRIN FOR PREPARING A TREATMENT FOR CYSTIC FIBROSIS - The invention relates to the use of a synergistic combination of at least one ion selected from the group including hypothiocyanites and/or hypohalites and of lactoferrin for preparing a pharmaceutical composition for treating cystic fibrosis. In one embodiment, the lactoferrin is one having a purity higher than 95% and substantially free of lipopolysaccharides, endotoxins, and angiogenins, and having an iron saturation level higher than 15%.01-26-2012
20120219640Anti-infective solution for athlete's foot - Disclosed herein is a novel use of highly diluted iodine solution in alcohol to effectively treat and prevent athlete's foot skin disease and disinfect and deodorize shoes without staining skin, clothing or surrounding materials.08-30-2012
20120308669CHOCOLATE CANDIES FORTIFIED WITH NATURAL AMINO ACIDS AND/OR HERBAL NUTRIENTS FOR RELIEF OF INSOMNIA, PMS, AND DIFFICULTY CONCENTRATING - A confection, such as chocolate, can be formulated to include naturally occurring amino acids and/or herbal extracts and/or plant extracts incorporated therein. The formulation allows a consumer to relieve health issues in a convenient, enjoyable manner. By incorporating the appropriate amino acids/herbal and plant extracts into a chocolate candy form, the confections can be formulated to provide relief of various ailments, such as insomnia, fatigue, PMS, difficulty concentrating and the like.12-06-2012
20120308670Topical Medicament for the Treatment of Psoriasis - A topical medicament for the treatment of psoriasis, comprising: chia oil, metallic iodine, virgin wax, a variety of oils of animal and plant origin, camphor, chlorophyll and benzoic acid, in a pharmaceutically acceptable emollient excipient base.12-06-2012
20130122115Rebound hoof pack - A specifically formulated composition comprised of Magnesium Sulfate (Epsom salt), Triodine-7 Solution (about 2% Iodine tincture, Potassium Iodide and Povidone Iodine), Arnica Montana 30x, and Pine Tar for the treatment of horse hoof soreness, Inflammation, and Infection (including abscesses). The formula contains specific amounts of each ingredient to pull out the infection while maintaining proper moisture balance in the hoof. This composition includes a sugar wax tackifier which creates an extremely sticky composition that sticks to the underside of the hoof WITHOUT WRAPPING, enabling the composition to be applied in 25 seconds rather than the 25 minutes it would take to mix a solution with all the ingredients and then wrapping the hoof with a diaper, vet wrap and duct tape to keep everything in place.05-16-2013
20130209581IODINATED ACTIVATED CHARCOAL FOR TREATING SYMPTOMS OF DEPRESSION - The present invention relates to the use of iodinated activated charcoal, optionally in combination with a bromide salt, in treatment of one or more symptom(s) caused by depression, wherein said symptom(s) is/are selected from the group consisting depressive mood, emotional fatigue, mental fatigue which can be chronic, burnout, withdrawal from social situations, anxiety, concentration problems, unpleasant heart palpitations, irregular heart beats, a feeling of pressure in the chest, irritable bowel syndrome and sexual dysfunction.08-15-2013
20130209582HYDROGEN IODIDE-CONTAINING HEALTH FOOD AND HYDROGEN IODIDE-CONTAINING DRUG, AND METHOD FOR PRODUCING SAME - To propose a health food or a drug, which comprises an iodine compound as a substitute for organic iodine and can exert a similar effect as organic iodine. To propose a method for producing a liquid to be used as a starting material for the aforesaid health food or drug. A health food and a drug each containing hydrogen iodide as the active ingredient. A method for producing a hydrogen iodide-containing solution, which comprises: an alkaline ion water preparation step for preparing alkaline ion water containing hydrogen peroxide; a sodium hydroxide production step for adding sodium to the alkaline ion water and thus producing sodium hydroxide; and a hydrogen iodide production step for, after the sodium hydroxide production step, adding iodine to the alkaline ion water and thus producing hydrogen iodide.08-15-2013
20130287865ANTIMICROBIAL SOLUTIONS AND METHODS - Antimicrobial solutions and delivery systems for them use liquid antimicrobial solutions with: at least 80% of total weight of a carrier liquid comprising water, alcohol or a mixture of water and alcohol; at least 0.0001% by weight of the solution of I10-31-2013
20140023728Iodine Liquid Soap, Dispenser and Method - A iodine liquid soap dispenser having a reservoir containing an iodine solution. The dispenser has a head communicating with the reservoir capable of delivering the solution to the exterior of the reservoir in the form of foam. The solution comprises water, iodine and iodide, and contains iodine in a range of concentration between 0.35% and 0.05% by weight of the solution. The solution may also contain one or more of the following: an anionic surfactant, Hydrogen Iodide, glycerine, and sodium hydroxide.01-23-2014
20140234442BROAD SPECTRUM ROOT CANAL FILING COMPOSITION FOR ENDODONTRIC USAGE - Disclosed is dental root canal filling (intracanal medicament) compositions that are effective against resistant root canal infections caused by 08-21-2014
20140271925MODULATING SURFACE AND AEROSOL IODINE DISINFECTANT SYSTEM - A method and apparatus for producing aqueous iodine solutions to be used as a surface and aerosol disinfectant under continuous and dynamic flow conditions for medical applications comprises dissolving iodine into a first water flow thereby producing a concentrated aqueous iodine solution. The iodine solution is stored and then blended with a second water flow to produce a predetermined iodine disinfectant concentration of aqueous iodine. The disinfectant concentration is then stored and chemically adjusted to polarize to the species of iodine. The disinfectant concentration is then thermodynamically adjusted to maximize retention and disinfection variables. The iodine disinfectant is then ready to be used in an application requiring disinfection using iodine.09-18-2014
20140271926METHODS OF USE OF GLUTAMINE SYNTHETASE INHIBITORS - A method of treating neoplastic growth in a subject includes administering a glutamine synthetase (GS) inhibitor to the subject having neoplastic growth. A glutamine synthetase inhibitor may be administered in combination with thalidomide, lenalidomide and/or pomalidomide. Responsiveness to thalidomide, lenalidomide or pomalidomide therapy is determined by the expression levels of glutamine synthetase in neoplastic cells.09-18-2014
20140271927COMPOSITION AND METHOD FOR TREATING NEUROPATHY - The present invention provides therapeutic and nutrient compositions comprising Alpha lipoic acid, gammalinolenic acid, chromium, selenium, and optionally iodine for the treatment of diabetic neuropaty. These compositions ameliorate the condition and symptoms associated with the complications of lack of triiodothyronine in the nucleus of target cells, in particular and the pathological effects of the vaso nervorum.09-18-2014
20150099011INACTIVATION OF PAPILLOMAVIRUS - A method of treating early papillomavirus infection of an orifice of a human or animal body including any canal associated with an orifice, comprising applying a viral inactivation agent to the orifice and/or canal in an amount effective to inactivate a portion of the virus infecting the orifice or canal. Apparatus is also disclosed.04-09-2015
20160106777NOVEL COMPOSITION METHOD OF USING THE SAME FOR THE TREATMENT OF LYME DISEASE - A composition for treating Lyme disease caused by 04-21-2016
20160199453TRANSDERMAL FORMULATIONS07-14-2016
424668000 Iodate 1
20130039997METHOD FOR THE ERADICATION OF PATHOGENS INCLUDING S. AUREUS AND ANTIBIOTIC RESISTANT MICROBES FROM THE UPPER RESPIRATORY TRACT OF MAMMALS AND FOR INHIBITING THE ACTIVATION OF IMMUNE CELLS - A method for killing or substantially eradicating a pathogen in the upper respiratory tract of a mammal is disclosed. The method comprises generating molecular iodine (I02-14-2013
424669000 Iodide 7
20160021889Treatment Liquid for Cleaning an Implant Part - A treatment liquid shall be suitably designed specifically for cleaning bacterially contaminated surfaces of bone implants, dental implants or other components contaminated with a biofilm. For this purpose, the treatment liquid according to the invention comprises, as one of its basic constituents, an aqueous solution of an acid which is provided with a metallic salt in such a manner that a conductivity of at least 30 mS/cm, preferably at least 75 mS/cm, and particularly preferably at least 150 mS/cm results.01-28-2016
424670000 Potassium iodide 5
20090068288Topical antiseptic veterinary solution - This invention relates to a veterinary antiseptic solution having three sources of iodine including elemental iodine, iodide salt and iodophor. The solution also includes at least one solvent such as alcohol, glycol or water. The solution is below the threshold concentration for elemental iodine of the List I controlled substances. The elemental iodine offers a rapid kill for bacteria. The iodophor offers lasting antibacterial properties. The iodide salt solubilizes elemental iodine and stabilizes the solution. The antiseptic solution forms a waterproof bandage with active antimicrobial properties when the alcohol dries.03-12-2009
20100215774FILM COMPRISING NITROGLYCERIN - The present invention is related to the composition and methods of manufacture of orally-dissolvable, edible films as a vehicle for the non-invasive administration of nitroglycerin and/or other active drugs through the mucosal tissues of the oral cavity. The films include a water soluble film-forming polymer such as pullulan. Methods for producing the films are also disclosed.08-26-2010
20120121729ANTITUSSIVE COMPOSITIONS COMPRISING MEMANTINE - Memantine compositions and methods of use are described herein. In some embodiments, the compositions comprise memantine and an absorption enhancer, or memantine and an elimination enhancer, or memantine and an absorption enhancer and an elimination enhancer.05-17-2012
20130108713COMPOSITION POSSESSING ANTIOXIDANT, IMMONOMODULATED, AND ANTITUMOROUS ACTION AND METHOD OF TREATING NEOPLASMS05-02-2013
20150297637ACTIVATED CARBON COMPRISING AN ADSORBED IODIDE SALT IN A METHOD FOR TREATING CHRONIC BRONCHITIS - The present invention provides activated carbon comprising an adsorbed iodide salt selected from the group of alkali metal iodides and earth alkali iodides, for use in a method for treating chronic bronchitis.10-22-2015
424671000 Sodium iodide 1
20110250296REVERSE VITAMIN K EFFECT VIA PHOTODYNAMIC OXIDATION TARGETED AT VASCULAR ENDOTHELIUM, FIBRIN AND BLOOD PLATELETS - A formulation or preparation for treating and preventing arterial and venous thrombi is provided. This preparation includes a non-metal containing photodynamic dye and a fat soluble vitamin. A method of administration for treatment and prophylaxis of arterial and venous thrombi is also provided. This method includes steps of: combining a non-metal containing photodynamic dye and a fat soluble vitamin; combining the non-metal containing photodynamic dye and fat soluble vitamin with a sodium solution; and administering the combination of non-metal containing photodynamic dye, fat soluble vitamin, and sodium solution as an intravenous drip.10-13-2011
424672000 Iodophors 2
20090169647LIQUID ANTISEPTIC COMPOSITIONS CONTAINING IODINE AND A SUGAR AND/OR SUGAR ALCOHOL - The present invention relates to compositions that contain iodine intended primarily for tissue antisepsis, particularly skin antisepsis.07-02-2009
20110274770ANTISEPTIC COMPOSITIONS AND METHODS - A skin antisepsis composition comprising a comprising a (C1-4)alcohol and water in a ratio of at least 60:40, a hydroxycarboxylic acid, a cationic film-forming polymer, and at least one antimicrobial agent; and methods of using the composition are provided.11-10-2011

Patent applications in class Elemental iodine or iodine compound

Patent applications in all subclasses Elemental iodine or iodine compound

Website © 2025 Advameg, Inc.